JP2015000064A5 - - Google Patents

Download PDF

Info

Publication number
JP2015000064A5
JP2015000064A5 JP2014123573A JP2014123573A JP2015000064A5 JP 2015000064 A5 JP2015000064 A5 JP 2015000064A5 JP 2014123573 A JP2014123573 A JP 2014123573A JP 2014123573 A JP2014123573 A JP 2014123573A JP 2015000064 A5 JP2015000064 A5 JP 2015000064A5
Authority
JP
Japan
Prior art keywords
subject
hematopoietic stem
bone marrow
progenitor cells
primary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014123573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015000064A (ja
JP6532653B2 (ja
Filing date
Publication date
Priority claimed from US13/919,241 external-priority patent/US9428748B2/en
Application filed filed Critical
Publication of JP2015000064A publication Critical patent/JP2015000064A/ja
Publication of JP2015000064A5 publication Critical patent/JP2015000064A5/ja
Application granted granted Critical
Publication of JP6532653B2 publication Critical patent/JP6532653B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014123573A 2013-06-17 2014-06-16 造血幹細胞の増殖方法 Active JP6532653B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/919,241 US9428748B2 (en) 2013-06-17 2013-06-17 Method of expanding hematopoietic stem cells
US13/919,241 2013-06-17

Publications (3)

Publication Number Publication Date
JP2015000064A JP2015000064A (ja) 2015-01-05
JP2015000064A5 true JP2015000064A5 (enExample) 2017-08-03
JP6532653B2 JP6532653B2 (ja) 2019-06-19

Family

ID=50942591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014123573A Active JP6532653B2 (ja) 2013-06-17 2014-06-16 造血幹細胞の増殖方法

Country Status (6)

Country Link
US (1) US9428748B2 (enExample)
EP (1) EP2816107B1 (enExample)
JP (1) JP6532653B2 (enExample)
DK (1) DK2816107T3 (enExample)
ES (1) ES2757508T3 (enExample)
HU (1) HUE046356T2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY203831A (en) * 2016-02-04 2024-07-19 Zhenglun Zhu Treatment and diagnosis of inflammatory disorders
GB201608944D0 (en) * 2016-05-20 2016-07-06 Ospedale San Raffaele And Fond Telethon Gene Tharapy
EP4146284A1 (en) 2020-05-06 2023-03-15 Cellectis S.A. Methods to genetically modify cells for delivery of therapeutic proteins
CA3177093A1 (en) 2020-05-06 2021-11-11 Cellectis S.A. Methods for targeted insertion of exogenous sequences in cellular genomes

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5908779A (en) 1993-12-01 1999-06-01 University Of Connecticut Targeted RNA degradation using nuclear antisense RNA
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
JP2003527096A (ja) * 1999-10-07 2003-09-16 エイブイアイ バイオファーマ, インコーポレイテッド C−mycアンチセンス処理した造血幹細胞組成物および方法
US20060247193A1 (en) * 2003-02-10 2006-11-02 National Institute Of Advanced Industrial Science And Technology Regulation of gene expression by dna interference
US20050054103A1 (en) * 2003-03-07 2005-03-10 Tony Peled Expansion of renewable stem cell populations using modulators of PI 3-kinase
CN101505780B (zh) 2006-02-22 2017-06-13 朱正崙 发育相关疾病的治疗
WO2007112084A2 (en) * 2006-03-24 2007-10-04 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
CN102575250B (zh) * 2009-07-15 2014-05-28 朱正仑 治疗和诊断免疫系统疾病的药物和制剂及其用途
WO2011028819A1 (en) * 2009-09-01 2011-03-10 The Trustees Of Columbia University In The City Of New York Synergistic transcription modules and uses thereof
EP2643454A4 (en) 2010-11-24 2014-05-21 Hong Gao EXPANSION OF HEMATOPOETIC STEM CELLS
US10066272B2 (en) 2011-06-10 2018-09-04 Zhenglun Zhu Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof
US20150086985A1 (en) * 2011-09-11 2015-03-26 Aurasense, Llc Cellular uptake control systems
CN105473710B (zh) * 2013-04-10 2019-08-23 朱正伦 同源盒转录因子VentX调控人树突状细胞的分化和成熟

Similar Documents

Publication Publication Date Title
MX2022006107A (es) Metodos y composiciones para dosificacion en terapia celular adoptiva.
MX384315B (es) Agente para el tratamiento y/o prevención de enfermedades asociadas con anormalidades inmunes.
BR112017014269A2 (pt) células exterminadoras naturais e usos das mesmas
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
JP2014240404A5 (enExample)
TW201613956A (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
MX2022008523A (es) Compuestos que interactuan con glicanos y metodos de uso.
MX2016001587A (es) Inhibidores de kdm1a para el tratamiento de enfermedades.
NZ739448A (en) Transgene genetic tags and methods of use
JP2014169326A5 (enExample)
JP2018522041A5 (enExample)
HRP20240798T1 (hr) Terapija matičnim stanicama kod patologija endometrija
JP2015000064A5 (enExample)
EA201790563A1 (ru) Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой
MD20120127A2 (en) Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV
HK1214752A1 (zh) 由产甲烷菌引起或与之相关的疾病及病状的诊断、选择及治疗方法
BR112018008931A8 (pt) ?compostos para tratamento de distúrbios hipoproliferativos?
RU2016108808A (ru) Терапевтическое применение vegf-c и ccbe1
JP2015517520A5 (enExample)
JP2015518835A5 (enExample)
CY1122042T1 (el) Συνθεση για χρηση στη θεραπεια του πονου που σχετιζεται με μεσοσπονδυλιο δισκο
JP2015044878A5 (enExample)
JP2016515123A5 (enExample)
WO2016066722A3 (en) Bacteriophage combinations for human or animal therapy
MD4763B1 (ro) Compoziţie farmaceutică